Indivior Wants States' Suboxone Product-Hop Claims Nixed

By Eric Kroh (December 13, 2016, 4:47 PM EST) -- Indivior Inc. asked a Pennsylvania federal court Monday to ax claims brought by more than 40 states that allege the company unlawfully stifled generic competition for opiate addiction treatment Suboxone, saying circuit courts have dismissed similar product-hopping allegations....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!